Article
Systemic cell therapy for muscular dystrophies
21 Dec 2020
Abstract excerpt
The intrinsic regenerative capacity of skeletal muscle makes it an excellent target for cell therapy. However, the potential of muscle tissue to renew is typically exhausted and insufficient in muscular dystrophies (MDs), a large group of heterogeneous genetic disorders showing progressive loss of skeletal muscle fibers. Cell therapy for MDs has to rely on suppletion with donor cells with high myogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
